Guido L. Poli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

The Silent Infection Load: How Lifelong Asymptomatic Infections May Contribute to Inflammaging as an Evolutionary Trade-off of Longevity.

The Silent Infection Load: How Lifelong Asymptomatic Infections May Contribute to Inflammaging as an Evolutionary Trade-off of Longevity.

Journal: Ageing research reviews

Published: March 19, 2026

In vitro Control of RNA Virus Infections by M1-Polarized Human Monocyte-Derived Macrophages.

In vitro Control of RNA Virus Infections by M1-Polarized Human Monocyte-Derived Macrophages.

Journal: The new microbiologica

Published: December 23, 2025

Malaria pigment hemozoin drives M1 pro-inflammatory macrophage polarization in vitro.

Malaria pigment hemozoin drives M1 pro-inflammatory macrophage polarization in vitro.

Journal: Scientific reports

Published: March 07, 2025

Correction for Kajaste-Rudnitski et al., "TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat Elements".

Correction for Kajaste-Rudnitski et al., "TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat Elements".

Journal: Journal of virology

Published: January 27, 2025

Restriction of Zika Virus Replication in Human Monocyte-Derived Macrophages by Pro-Inflammatory (M1) Polarization.

Restriction of Zika Virus Replication in Human Monocyte-Derived Macrophages by Pro-Inflammatory (M1) Polarization.

Journal: International journal of molecular sciences

Published: October 26, 2024

SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects.

SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects.

Journal: Viruses

Published: August 03, 2024

Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimens.

Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimens.

Journal: Frontiers in medicine

Published: March 17, 2024

Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.

Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.

Journal: Nature

Published: September 05, 2023

Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells.

Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 27, 2023

FAM46C Is an Interferon-Stimulated Gene That Inhibits Lentiviral Particle Production by Modulating Autophagy.

FAM46C Is an Interferon-Stimulated Gene That Inhibits Lentiviral Particle Production by Modulating Autophagy.

Journal: Microbiology spectrum

Published: June 26, 2023

Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection.

Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection.

Journal: International journal of molecular sciences

Published: December 16, 2022

Heparin Protects Human Neural Progenitor Cells from Zika Virus-Induced Cell Death While Preserving Their Differentiation into Mature Neuroglial Cells.

Heparin Protects Human Neural Progenitor Cells from Zika Virus-Induced Cell Death While Preserving Their Differentiation into Mature Neuroglial Cells.

Journal: Journal of virology

Published: September 19, 2022

Showing 1-12 of 75

Last Updated: 09/26/2026